Efficacy of Ceftriaxone Monotherapy Comparable to Dual Therapy for Extragenital Gonorrhea
Investigators compared with efficacy of high-dose ceftriaxone monotherapy against that of dual therapy for Neisseria gonorrhoeae in men who have sex with men.
Chlamydia
Effects of Targeted Antibiotics to Eliminate Community-Wide Trachoma
To determine if targeted antibiotics prevent community transmission of ocular strains of chlamydia that cause trachoma, investigators conducted a cluster-randomized trial.
CDC: US STD Rate at Record High Again
Early data from 2020 shows about 2.5 million cases of chlamydia, gonorrhea, and syphilis in 2019, which is an almost 30% increase in these STDs between 2015 and 2019.
Mycoplasma genitalium Coinfection in Women With Chlamydia trachomatis
The prevalence of Mycoplasma genitalium coinfection in women with chlamydial infection was low and no patient characteristics predicted coinfection.
Initial Treatment for Chlamydia Improves Pelvic Inflammatory Disease Outcomes
Initial treatment for C trachomatis in hospitalized women with PID showed significant improvements in rates of surgical intervention and mortality.
High Sensitivity, Specificity for Chlamydia Point-of-Care Test
Polymerase chain reaction test has high sensitivity and specificity for vaginal swab samples.
NYC Sexual Health Clinics See Rise in Anorectal Lymphogranuloma Venereum
A rise in anorectal lymphogranuloma venereum, caused by Chlamydia trachomatis invasive serovars, observed from 2012-2015 in NYC sexual health clinics.
CDC: Increase in Rate of STDs for Fourth Consecutive Year in the United States
Nearly 2.3 million cases of chlamydia, gonorrhea, and syphilis were diagnosed in the United States in 2017.
Point-of-Care Molecular Test Effectively Detects Chlamydia, Gonorrhea
A new point-of-care molecular test for CT and NG has the same accuracy as conventional nucleic acid amplification tests in certain settings.
Doxycycline Post-Exposure Prophylaxis May Prevent STIs in High-Risk MSM
In the future, doxycycline post-exposure prophylaxis might become an effective addition to a combined intervention approach to reduce the high rate of STIs in PrEP users.
- Loading...
Loading...
Next post in Sexually Transmitted Diseases
Loading... 
Loading...